Advanced searches left 3/3

Diabetic Macular Edema - Springer Nature

Summarized by Plex Scholar
Last Updated: 02 September 2022

* If you want to update the article please login/register

Management of Diabetic Macular Edema: Guidelines from the Emirates Society of Ophthalmology

Retinopathy has been reported in 19% of the diabetic population of Dubai, with diabetes affecting up to 40% of individuals aged over 55 years. Despite the prevalence of diabetic retinal disorders, there are no national guidelines on diabetic macular edema management. If contraindicated, the Macular laser no longer plays a primary role in center-involving DME, and anti-vascular endothelial growth factor therapy should be considered as first-line therapy for all patients. In addition, recommendations for the care of DME in special circumstances, relapsing, and refractory DME are also discussed.

Source link: https://doi.org/10.1007/s40123-022-00547-2


Classification of diabetic macular edema severity using deep learning technique

Purpose About the retinal region of the diabetic macular region, there is a mild case of diabetic macular edema. The article discusses transfer learning's capability to find cases of DME from retinal fundus photographs in order to highlight this. Methods used to extract the useful set of feature vectors from the fundus images, which are then fed into a few additional completely connected layers and then onto the classification layer to classify DME instances. A total of 577 fundus training photos from 3 DME classes was used to develop the new model, and 103 fundus testing photos were used to verify the new model's classification into one of the three DME cases.

Source link: https://doi.org/10.1007/s42600-022-00233-z


Optical coherence tomography angiography analysis of changes in the foveal avascular zone in eyes with diabetic macular edema treated with intravitreal anti-vascular endothelial growth factor

Using optical coherence tomography angiography, we can examine the changes in foveal avascular zone area, perimeter, and circularity in the superficial and deep capillary plexuses in eyes with diabetic macular edema treated with intravitreal anti-VEGF. Methods This prospective observational study included 56 eyes from 32 patients with DME who had intravitreal anti-VEGF (intravitreal anti-VEGF). Results The mean number of intravitreal anti-VEGF injections received during the observation period was 4. 60 u00b1 0. 82, according to the study's results. Conclusions The FAZ area, perimeter, and circularity of the SCP and DCP as measured by OCTA remained stable during the first six months of intravitreal anti-VEGF therapy in eyes with DME. Although there were no significant changes in the FAZ, intravitreal anti-VEGF therapy resulted in reduced CST and better BCVA, which was also improved BCVA.

Source link: https://doi.org/10.1186/s40942-022-00406-z

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions